Considerations for Designing an Optimal First in Human Radiopharmaceutical Trial
Time: 11:45 am
day: Day One ESC AM
Details:
• Considerations on candidate selection when working with a multidisciplinary team
• Evolving strategy and lessons learned moving from lab to clinic
• FIH study design dynamics about safety, dosimetry and PK/PD from Th227 to Ac225
